Stocks-ENFN-Enfusion

ENFN Enfusion

8.37 -0.29 (-3.35%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Enfusion's revenues increased by 34.60% and amounted to 150.35M. Net income increased by 95.30% to -13.26M. Net assets increased by 6.16% to 103.44M and EPS increased from -2.50 to -0.09.
ENFN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
67.69%
Net Profit Margin
-30.07%
Operating Margin
7.00%
Return On Investment
-49.02%